Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.13 | 0.7 |
mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.031 | 0.7 |
mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.7 |